Skip to main content


Figure 4 | Cost Effectiveness and Resource Allocation

Figure 4

From: Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost

Figure 4

Contribution of clinical variables to median COPD cost. + variable present; - variable not present CAD-coronary artery disease; HTN-hypertension; COPD-chronic obstructive pulmonary disease; SAMA-short acting anti-muscarinic agonist; LAMA-long acting anti-muscarinic agonist; LABA-long acting beta agonist; ICS-inhaled corticosteroid.

Back to article page